Azadirone, a Limonoid Tetranortriterpene, Induces Death Receptors and Sensitizes Human Cancer Cells to Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) through a p53 Protein-independent Mechanism
Author:
Publisher
Elsevier BV
Subject
Cell Biology,Molecular Biology,Biochemistry
Reference54 articles.
1. Safety and antitumor activity of recombinant soluble Apo2 ligand;Ashkenazi;J. Clin. Invest,1999
2. Resistance of melanoma cells to TRAIL does not result from upregulation of antiapoptotic proteins by NF-κB but is related to downregulation of initiator caspases and DR4;Kurbanov;Oncogene,2007
3. Modulation of TRAIL resistance in colon carcinoma cells: different contributions of DR4 and DR5;van Geelen;BMC Cancer,2011
4. Progressive resistance of BTK-143 osteosarcoma cells to Apo2L/TRAIL-induced apoptosis is mediated by acquisition of DcR2/TRAIL-R4 expression: resensitisation with chemotherapy;Bouralexis;Br. J. Cancer,2003
5. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors;Sheridan;Science,1997
Cited by 60 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Nimbolide: promising agent for prevention and treatment of chronic diseases (recent update);Food & Nutrition Research;2024-03-18
2. A review on the impact of TRAIL on cancer signaling and targeting via phytochemicals for possible cancer therapy;International Journal of Biological Macromolecules;2023-12
3. Limonoids from neem (Azadirachta indica A. Juss.) are potential anticancer drug candidates;Medicinal Research Reviews;2023-08-17
4. Azadiradione (AZD) neem biomass derived limonoid: extraction, characterization, and potential biological activities with special reference to anti-microbial and anti-cancer activities;South African Journal of Botany;2023-07
5. Exploring the therapeutic potential of Neem (Azadirachta Indica) for the treatment of prostate cancer: a literature review;Annals of Translational Medicine;2022-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3